Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Endogenous Glucagon-like Peptide-1 (GLP-1) in Improved Glucose Tolerance After Two Different Types of Bariatric Surgery

NCT01153438 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01153438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01153438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Endogenous Glucagon-like Peptide-1 (GLP-1) in Improved Glucose Tolerance After Two Different Types of Bariatric Surgery
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2013
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery, obesity, type 2 diabetes